Genetic Links Between Ankylosing Spondylitis and Crohn’s Disease Treatment Needs
Author Information
Author(s): Omar Mahmud, Omar Mohammad, Patt Yonatan Shneor, Ukashi Offir, Sharif Yousra, Lahat Adi, Selinger Christian Phillip, Sharif Kassem, Caballero-Mateos Antonio M.
Primary Institution: Faculty of Medicine, Tel-Aviv University
Hypothesis
Does genetic predisposition to Ankylosing Spondylitis increase the likelihood of requiring advanced therapy in Crohn’s Disease?
Conclusion
Genetic factors associated with Ankylosing Spondylitis may lead to a higher need for second-line treatments in Crohn’s Disease.
Supporting Evidence
- The study found a significant association between AS genetic predisposition and the need for second-line treatments in CD.
- Multiple MR methods confirmed the robustness of the findings.
- Exclusion of an influential SNP did not negate the statistical significance of the results.
- Genetic predisposition to AS may indicate a more severe disease phenotype in CD.
Takeaway
If someone has a genetic risk for a disease called Ankylosing Spondylitis, they might need stronger medicine for another disease called Crohn's Disease.
Methodology
The study used two-sample Mendelian randomization to analyze genetic data from large datasets for both conditions.
Potential Biases
Potential residual pleiotropy could affect the results.
Limitations
The study primarily used data from individuals of European ancestry, which may limit the generalizability of the findings.
Participant Demographics
The study included participants from GWAS datasets, primarily of European descent.
Statistical Information
P-Value
9.120082 × 10−8
Confidence Interval
95% CI: 1.59 to 2.94
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website